Morningstar® Stock Report™

AbbVie Inc ABBV

Gewinnmarge (% des Umsatzes)
20192020202120222023
Ertrag100,00%100,00%100,00%100,00%100,00%
Betriebskosten22,36%33,59%31,04%30,00%37,58%
Bruttogewinn77,64%66,41%68,96%70,00%62,42%
Vertriebsgemeinkosten20,87%24,67%21,97%26,29%23,70%
Forschung und Entwicklung19,26%14,32%12,61%11,21%14,13%
Umsatzrendite40,19%27,42%33,61%32,41%24,92%
Net Int, Inc and Other65,51%34,84%56,72%55,62%36,42%
EBIT Marge25,33%7,42%23,11%23,21%11,51%
Ertragskraft
20192020202120222023
Steuersatz1,64%-2,67%2,56%2,81%2,54%
Nettomarge23,69%10,08%20,54%20,39%8,95%
Gesamtkapitalrendite10,563,807,728,263,52
Financial Leverage0,0011,519,518,0413,00
Eigenkapitalsrendite0,00185,8180,5272,1534,91